IN2014MU00195A - - Google Patents

Info

Publication number
IN2014MU00195A
IN2014MU00195A IN195MU2014A IN2014MU00195A IN 2014MU00195 A IN2014MU00195 A IN 2014MU00195A IN 195MU2014 A IN195MU2014 A IN 195MU2014A IN 2014MU00195 A IN2014MU00195 A IN 2014MU00195A
Authority
IN
India
Prior art keywords
compound
formula
preparation
disclosed
Prior art date
Application number
Other languages
English (en)
Inventor
Sanjeev Joshi
Sunil Bhaginath Jadhav
Vipul Rane
Satish Bhawsar
Prasad Keshav Deshpande
Ravindra Dattatraya Yeole
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to EP14837077.8A priority Critical patent/EP3105231A1/en
Priority to IN195MU2014 priority patent/IN2014MU00195A/en
Priority to US15/108,296 priority patent/US9771364B2/en
Priority to PCT/IB2014/067377 priority patent/WO2015110885A1/en
Publication of IN2014MU00195A publication Critical patent/IN2014MU00195A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
IN195MU2014 2014-01-21 2014-12-29 IN2014MU00195A (zh)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP14837077.8A EP3105231A1 (en) 2014-01-21 2014-12-29 A process for preparation of (2s,5r)-6-sulphooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
IN195MU2014 IN2014MU00195A (zh) 2014-01-21 2014-12-29
US15/108,296 US9771364B2 (en) 2014-01-21 2014-12-29 Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
PCT/IB2014/067377 WO2015110885A1 (en) 2014-01-21 2014-12-29 A process for preparation of (2s,5r)-6-sulphooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN195MU2014 IN2014MU00195A (zh) 2014-01-21 2014-12-29

Publications (1)

Publication Number Publication Date
IN2014MU00195A true IN2014MU00195A (zh) 2015-08-28

Family

ID=52478023

Family Applications (1)

Application Number Title Priority Date Filing Date
IN195MU2014 IN2014MU00195A (zh) 2014-01-21 2014-12-29

Country Status (4)

Country Link
US (1) US9771364B2 (zh)
EP (1) EP3105231A1 (zh)
IN (1) IN2014MU00195A (zh)
WO (1) WO2015110885A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105143225A (zh) 2013-03-08 2015-12-09 沃克哈特有限公司 一种制备(2s,5r)-7-氧代-6-磺酰氧基-2-[((3r)-哌啶-3-羰基)-肼基羰基]-1,6-二氮杂-双环[3.2.1]辛烷的方法
CN110446708B (zh) 2017-07-21 2022-12-02 安塔比奥公司 化学化合物
ES2928152T3 (es) 2017-12-01 2022-11-15 Qilu Pharmaceutical Co Ltd Forma cristalina de un inhibidor de beta-lactamasa y método de preparación de la misma
EP3572411A1 (en) 2018-05-21 2019-11-27 Antabio SAS Thiazole derivatives as metallo-beta-lactamase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2748165T3 (en) * 2011-08-27 2016-12-19 Wockhardt Ltd 1,6-diazabicyclo [3,2,1] octane-7-ON DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
WO2014135931A1 (en) * 2013-03-08 2014-09-12 Wockhardt Limited A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]- octane

Also Published As

Publication number Publication date
US9771364B2 (en) 2017-09-26
US20160340359A1 (en) 2016-11-24
WO2015110885A1 (en) 2015-07-30
EP3105231A1 (en) 2016-12-21

Similar Documents

Publication Publication Date Title
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
NZ726356A (en) Processes for preparing antiviral compounds
GR20140100479A (el) Συνθεση λιραγλουτιδης
AU2016277367A8 (en) Aryl sulfonohydrazides
IN2014CH00247A (zh)
MX369501B (es) Proceso para la preparación de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno.
MX2020003020A (es) Compuestos de aminocarbonilcarbamato.
MX2016015543A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles a partir de hexafluoropropeno.
MA39843A (fr) Pyridine-2-amides utiles comme agonistes de cb2
PH12018550165A1 (en) An improved process for the preparation of butorphanol tartrate
IN2014MU01192A (zh)
IN2014MU00195A (zh)
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
MX2019004024A (es) Metodo para preparar acetofenonas sustituidas con ciclopropilo.
IN2014MU00194A (zh)
IN2014MU01196A (zh)
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2017002609A (es) Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso.
IN2014CH00444A (zh)
CL2016002925A1 (es) Procedimiento mejorado para preparar ácidos crotónicos sustituidos
IN2014MU00858A (zh)
IN2014MU01195A (zh)
IN2014MU00072A (zh)